MITPF Stock - Mithra Pharmaceuticals S.A.
Unlock GoAI Insights for MITPF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $40.16M | $67.00M | $22.67M | $9.03M | $96.52M |
| Gross Profit | $5.99M | $35.43M | $-3,482,000 | $-4,300,000 | $88.26M |
| Gross Margin | 14.9% | 52.9% | -15.4% | -47.6% | 91.4% |
| Operating Income | $-69,321,000 | $-33,442,000 | $-92,686,000 | $-90,253,000 | $20.42M |
| Net Income | $-173,502,000 | $-59,620,000 | $-116,875,000 | $-92,086,000 | $-26,564,000 |
| Net Margin | -432.1% | -89.0% | -515.6% | -1019.8% | -27.5% |
| EPS | $-2.51 | $-1.22 | $-2.69 | $-2.25 | $-0.70 |
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.
Visit WebsiteEarnings History & Surprises
MITPFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 30, 2025 | — | — | — | — |
Q3 2024 | Sep 26, 2024 | — | — | — | — |
Q2 2024 | May 30, 2024 | — | — | — | — |
Q1 2024 | Mar 8, 2024 | — | $-1.14 | — | — |
Q4 2023 | Dec 30, 2023 | — | $-1.19 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.96 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.48 | — | — |
Q1 2023 | Mar 7, 2023 | — | $-0.26 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-0.56 | — | — |
Q3 2022 | Sep 23, 2022 | — | — | — | — |
Q2 2022 | Jun 29, 2022 | — | $-0.73 | — | — |
Q1 2022 | Mar 8, 2022 | — | — | — | — |
Q4 2021 | Dec 30, 2021 | — | $-1.61 | — | — |
Q3 2021 | Sep 24, 2021 | — | — | — | — |
Q2 2021 | Jun 29, 2021 | — | $-1.51 | — | — |
Q1 2021 | Mar 9, 2021 | — | — | — | — |
Q4 2020 | Dec 30, 2020 | — | $-1.66 | — | — |
Q3 2020 | Sep 24, 2020 | — | — | — | — |
Q2 2020 | Jun 29, 2020 | — | $-0.97 | — | — |
Q1 2020 | Mar 9, 2020 | — | — | — | — |
Latest News
Frequently Asked Questions about MITPF
What is MITPF's current stock price?
What is the analyst price target for MITPF?
What sector is Mithra Pharmaceuticals S.A. in?
What is MITPF's market cap?
Does MITPF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MITPF for comparison